Abcellera Biologics Inc (ABCL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ABCL? Forum Prognose

Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	303.40% 17.08	4.235	6.507	7.323	9.954
Operating Expenses	0.34% 66.67	66.89	100.17	100.78	64.85
Benefits Costs and Expenses	6.63% 53.43	57.22	69.14	55.51	52.70
Costs And Expenses	6.63% 53.43	57.22	69.14	55.51	52.70
Depreciation and Amortization	2.61% 5.47	5.331	-	-	4.844
Operating Income/Loss	20.87% -49.59	-62.66	-93.66	-93.45	-54.89
Nonoperating Income/Loss	36.84% 13.24	9.676	31.03	45.27	12.15
Income/Loss From Continuing Operations Before Tax	31.41% -36.34	-52.98	-62.63	-48.19	-42.75
Income Tax Expense/Benefit	78.04% -1.617	-7.363	-11.53	-11.26	-2.137
Income/Loss From Continuing Operations After Tax	23.88% -34.73	-45.62	-51.11	-36.93	-40.61
Net Income/Loss	23.88% -34.73	-45.62	-51.11	-36.93	-40.61
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.27% 298.51	297.69	294.85	294.22	292.72
Diluted Average Shares	0.27% 298.51	297.69	294.85	294.22	292.72
Basic Earnings Per Share	20.00% -0.12	-0.15	-0.17	-0.13	-0.14
Diluted Earnings Per Share	20.00% -0.12	-0.15	-0.17	-0.13	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$21.35

5.74%

INCY

$83.80

1.12%

GMAB

$31.81

0.13%

BNTX

$102.06

2.32%

INSM

$162.33

1.26%

ONC

$320.10

4.68%